Status unknownNCT03806647Updated Jan 18, 2019

Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 1)

An observational study in Amyotrophic Lateral Sclerosis, sponsored by Taipei Veterans General Hospital, Taiwan. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2019-01-18.

Sponsored by Taipei Veterans General Hospital, Taiwan · Observational

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Recruiting — may be out of date.

Study type: Observational
Model: Cohort
Time perspective: Retrospective
Enrollment: 20
Ages: 20 Years and older
Sex: All

Study summary

The research is aimed to explore the needs of clinical patients and their caregiver,so as to provide suggestions to the designer of the communication system.

Read the detailed description

To promote and develop a smart communication system is helpful to patients with amyotrophic lateral sclerosis (ALS),especially for stage 3 and stage 4 (late stage). Through the needs assessment, the research is aimed to explore the needs of clinical patients and their caregiver,so as to provide suggestions to the designer of the communication system.

Conditions studied

Amyotrophic Lateral Sclerosis

Browse trials for

Keywords

Amyotrophic lateral sclerosis, ALS, communication, needs

In context

Amyotrophic Lateral Sclerosis

1,000 studies on the registry are indexed under Amyotrophic Lateral Sclerosis; 284 are open to participants now.

This study's planned enrollment of 20 is below the median of 103 across 272 observational studies indexed under Amyotrophic Lateral Sclerosis.

Browse Amyotrophic Lateral Sclerosis studies →

Lead sponsor

Taipei Veterans General Hospital, Taiwan is the lead sponsor of 338 studies on the registry; 74 are open to participants now.

Browse Taipei Veterans General Hospital, Taiwan studies →

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 20 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Participants with ALS were recruited from ALS clinics(Taipei Veterans General Hospital, Taiwan, R.O.C),20 participants. Participants were eligible for this study if they were diagnosed with definite, probable, probable laboratory-supported, or possible ALS according to the criteria (Brooks et al., 2000).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Clinical diagnosis of ALS
Taiwanese and used traditional Chinese(Mandarin).
If they were older than age 20 years.

Exclusion criteria

Exclusion Criteria:

Frontotemporal dementia, severe depression, or schizophrenia.
If they cannot complete the questionnaire with researchers or family members help.

Study design

Observational model: Cohort
Time perspective: Retrospective
Enrollment: 20 participants (estimated)
Patient registry: No

What researchers measure

Primary outcomes

Amyotrophic Lateral Sclerosis Supportive Care Needs (ALSSCN)
The ALSSCN consisted of 37 items with seven domains: physical, psychological, emotional, spiritual, social, informational, and practical needs.
Time frame: 2018.10.01~2020.04.31

Study locations

1 of 1 sites recruiting

Taipei Veterans General Hospital
Taipei, TW 11217, Taiwan
Recruiting

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

Timeline

Tracking since Sep 25, 2026

ElapsedEstimatedEstimated, not yet reached

Started Sep 2018 (actual). Primary completion is estimated for Apr 2020, 19 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered: Jan 14, 2019
First posted: Jan 16, 2019
StartActual: Sep 1, 2018
Primary completionEst.: Apr 1, 2020
CompletionEst.: Sep 1, 2020
Last update: Jan 18, 2019

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Jan 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT03806647
Lead sponsor: Taipei Veterans General Hospital, Taiwan
Responsible party: Sponsor
First posted: Jan 16, 2019
Start date: Sep 1, 2018
Primary completion: Apr 1, 2020 (estimated)
Completion: Sep 1, 2020 (estimated)
Last update: Jan 18, 2019

Study contacts

Si Huei Li

Contact

lableesihuei@gmail.com

886-2871-2121 ext. 2931

Cheng Liang Chou

Contact

cl_chou@vghtpe.gov.tw

886-2871-2121 ext. 7361

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Amyotrophic Lateral Sclerosis →

Other studies from this sponsor

Taipei Veterans General Hospital, Taiwan →

Start the discussion